methotrexate has been researched along with Cystadenoma in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adcock, RA; McKeown, J; Muskovin, M; Sherrill, W; Spratt, JS | 1 |
Euler-Rolle, J; Kerstan, E; Tuchmann, A | 1 |
Foley, JF; Kessinger, A; Lemon, HM | 1 |
Ehrhart, H; Frank, S; Götz, A; Meister, P; Penning, W; Richter, K; Schmidt, D | 1 |
Donegan, WL; Harris, HS | 1 |
Schein, PS | 1 |
Rietberg, M | 1 |
Cohen, SM; Greenspan, EM; Weiner, MJ | 1 |
1 review(s) available for methotrexate and Cystadenoma
Article | Year |
---|---|
Chemotherapy in advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Cystadenocarcinoma; Cystadenoma; Drug Therapy, Combination; Endometriosis; Female; Fluorouracil; Humans; Laparoscopy; Mesonephroma; Methotrexate; Middle Aged; Ovarian Neoplasms; Palliative Care; Radiography | 1973 |
7 other study(ies) available for methotrexate and Cystadenoma
Article | Year |
---|---|
Clinical delivery system for intraperitoneal hyperthermic chemotherapy.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cystadenoma; Drug Therapy, Combination; Hot Temperature; Humans; Male; Methotrexate; Peritoneal Neoplasms; Thiotepa | 1980 |
[Pseudomyxoma of the peritoneum (author's transl)].
Topics: Ascites; Cystadenoma; Female; Fluorouracil; Humans; Hydrazines; Methotrexate; Middle Aged; Myxoma; Ovarian Neoplasms; Peritoneal Diseases; Podophyllin; Prednisolone | 1978 |
Quadrichemotherapy for advanced ovarian carcinoma.
Topics: Carcinoma; Cyclophosphamide; Cystadenocarcinoma; Cystadenoma; Dactinomycin; Drug Therapy, Combination; Female; Humans; Methotrexate; Ovarian Neoplasms; Vincristine | 1976 |
[1st report on programmed chemotherapy of ovarian carcinoma].
Topics: Adenocarcinoma; Antineoplastic Agents; Cyclophosphamide; Cystadenocarcinoma; Cystadenoma; Drug Therapy, Combination; Endometriosis; Female; Fluorouracil; Follow-Up Studies; Granulosa Cell Tumor; Humans; Methotrexate; Ovarian Neoplasms; Time Factors; Vincristine | 1975 |
Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
Topics: Age Factors; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cystadenoma; Drug Synergism; Eye Neoplasms; Female; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Laryngeal Neoplasms; Male; Mechlorethamine; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasms; Pharyngeal Neoplasms; Remission, Spontaneous; Skin Neoplasms | 1972 |
The use of oral methotrexate (mtx) in the treatment of tumours in the head and neck-region.
Topics: Adenocarcinoma; Administration, Oral; Aged; Carcinoma, Adenoid Cystic; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cystadenoma; Ear Neoplasms; Female; Head; Head and Neck Neoplasms; HeLa Cells; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Osteosarcoma | 1970 |
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting | 1972 |